Coating of Mesh Grafts for Prolapse and Urinary Incontinence Repair with Autologous Plasma

Exploration Stage of a Surgical Innovation

Dimitri Barski, Holger Gerullis, Evangelos Georgas, Andreas Bär, Bernhard Lammers, Albert Ramon, Dirk Ysebaert, Bernd Klosterhalfen, M. Borós, Thomas Otto

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Purpose. Optimized biocompatibility is a major requirement for alloplastic materials currently applied for stress urinary incontinence (SUI) and pelvic organ prolapse (POP) repair. In the preliminary studies the mesh modification by coating with autologous plasma resulted in the increased adherence score in vitro and improved biocompatibility in an animal model. The first use of plasma coated meshes in human is presented. Materials and Methods. Between 04/2013 and 05/2014, 20 patients with the indication for SUI and POP repair were selected in a single institution. The applied meshes were modified by autologous plasma coating prior to implantation. A retrospective chart review for peri- and early postoperative complications was performed. Functional outcome and QoL were evaluated pre- and postoperatively. Results. The functional outcome and QoL improved significantly in all groups. Two reoperations (Grade IIIB) with the release of TVT-mesh in anesthesia due to the obstruction were needed. No other severe complications were registered. Conclusion. For the first time we applied a mesh modification in a human setting according to IDEAL criteria of surgical innovations. The procedure of mesh coating with autologous plasma is safe and a prospective randomized trial proving a positive effect of plasma coating on the biocompatibility and morbidity outcome with long-term registry is planned.

Original languageEnglish
Article number296498
JournalBioMed Research International
Volume2014
DOIs
Publication statusPublished - 2014

Fingerprint

Prolapse
Urinary Incontinence
Grafts
Repair
Innovation
Transplants
Plasmas
Coatings
Biocompatibility
Pelvic Organ Prolapse
Stress Urinary Incontinence
Reoperation
Registries
Animals
Anesthesia
Animal Models
Morbidity

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)

Cite this

Coating of Mesh Grafts for Prolapse and Urinary Incontinence Repair with Autologous Plasma : Exploration Stage of a Surgical Innovation. / Barski, Dimitri; Gerullis, Holger; Georgas, Evangelos; Bär, Andreas; Lammers, Bernhard; Ramon, Albert; Ysebaert, Dirk; Klosterhalfen, Bernd; Borós, M.; Otto, Thomas.

In: BioMed Research International, Vol. 2014, 296498, 2014.

Research output: Contribution to journalArticle

Barski, Dimitri ; Gerullis, Holger ; Georgas, Evangelos ; Bär, Andreas ; Lammers, Bernhard ; Ramon, Albert ; Ysebaert, Dirk ; Klosterhalfen, Bernd ; Borós, M. ; Otto, Thomas. / Coating of Mesh Grafts for Prolapse and Urinary Incontinence Repair with Autologous Plasma : Exploration Stage of a Surgical Innovation. In: BioMed Research International. 2014 ; Vol. 2014.
@article{5500aa507970499395534cb00f1a9dec,
title = "Coating of Mesh Grafts for Prolapse and Urinary Incontinence Repair with Autologous Plasma: Exploration Stage of a Surgical Innovation",
abstract = "Purpose. Optimized biocompatibility is a major requirement for alloplastic materials currently applied for stress urinary incontinence (SUI) and pelvic organ prolapse (POP) repair. In the preliminary studies the mesh modification by coating with autologous plasma resulted in the increased adherence score in vitro and improved biocompatibility in an animal model. The first use of plasma coated meshes in human is presented. Materials and Methods. Between 04/2013 and 05/2014, 20 patients with the indication for SUI and POP repair were selected in a single institution. The applied meshes were modified by autologous plasma coating prior to implantation. A retrospective chart review for peri- and early postoperative complications was performed. Functional outcome and QoL were evaluated pre- and postoperatively. Results. The functional outcome and QoL improved significantly in all groups. Two reoperations (Grade IIIB) with the release of TVT-mesh in anesthesia due to the obstruction were needed. No other severe complications were registered. Conclusion. For the first time we applied a mesh modification in a human setting according to IDEAL criteria of surgical innovations. The procedure of mesh coating with autologous plasma is safe and a prospective randomized trial proving a positive effect of plasma coating on the biocompatibility and morbidity outcome with long-term registry is planned.",
author = "Dimitri Barski and Holger Gerullis and Evangelos Georgas and Andreas B{\"a}r and Bernhard Lammers and Albert Ramon and Dirk Ysebaert and Bernd Klosterhalfen and M. Bor{\'o}s and Thomas Otto",
year = "2014",
doi = "10.1155/2014/296498",
language = "English",
volume = "2014",
journal = "BioMed Research International",
issn = "2314-6133",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Coating of Mesh Grafts for Prolapse and Urinary Incontinence Repair with Autologous Plasma

T2 - Exploration Stage of a Surgical Innovation

AU - Barski, Dimitri

AU - Gerullis, Holger

AU - Georgas, Evangelos

AU - Bär, Andreas

AU - Lammers, Bernhard

AU - Ramon, Albert

AU - Ysebaert, Dirk

AU - Klosterhalfen, Bernd

AU - Borós, M.

AU - Otto, Thomas

PY - 2014

Y1 - 2014

N2 - Purpose. Optimized biocompatibility is a major requirement for alloplastic materials currently applied for stress urinary incontinence (SUI) and pelvic organ prolapse (POP) repair. In the preliminary studies the mesh modification by coating with autologous plasma resulted in the increased adherence score in vitro and improved biocompatibility in an animal model. The first use of plasma coated meshes in human is presented. Materials and Methods. Between 04/2013 and 05/2014, 20 patients with the indication for SUI and POP repair were selected in a single institution. The applied meshes were modified by autologous plasma coating prior to implantation. A retrospective chart review for peri- and early postoperative complications was performed. Functional outcome and QoL were evaluated pre- and postoperatively. Results. The functional outcome and QoL improved significantly in all groups. Two reoperations (Grade IIIB) with the release of TVT-mesh in anesthesia due to the obstruction were needed. No other severe complications were registered. Conclusion. For the first time we applied a mesh modification in a human setting according to IDEAL criteria of surgical innovations. The procedure of mesh coating with autologous plasma is safe and a prospective randomized trial proving a positive effect of plasma coating on the biocompatibility and morbidity outcome with long-term registry is planned.

AB - Purpose. Optimized biocompatibility is a major requirement for alloplastic materials currently applied for stress urinary incontinence (SUI) and pelvic organ prolapse (POP) repair. In the preliminary studies the mesh modification by coating with autologous plasma resulted in the increased adherence score in vitro and improved biocompatibility in an animal model. The first use of plasma coated meshes in human is presented. Materials and Methods. Between 04/2013 and 05/2014, 20 patients with the indication for SUI and POP repair were selected in a single institution. The applied meshes were modified by autologous plasma coating prior to implantation. A retrospective chart review for peri- and early postoperative complications was performed. Functional outcome and QoL were evaluated pre- and postoperatively. Results. The functional outcome and QoL improved significantly in all groups. Two reoperations (Grade IIIB) with the release of TVT-mesh in anesthesia due to the obstruction were needed. No other severe complications were registered. Conclusion. For the first time we applied a mesh modification in a human setting according to IDEAL criteria of surgical innovations. The procedure of mesh coating with autologous plasma is safe and a prospective randomized trial proving a positive effect of plasma coating on the biocompatibility and morbidity outcome with long-term registry is planned.

UR - http://www.scopus.com/inward/record.url?scp=84935887859&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84935887859&partnerID=8YFLogxK

U2 - 10.1155/2014/296498

DO - 10.1155/2014/296498

M3 - Article

VL - 2014

JO - BioMed Research International

JF - BioMed Research International

SN - 2314-6133

M1 - 296498

ER -